Wilmore Webley earned his Ph.D. in microbiology with expertise in immunology, pathogenic bacteriology, and host-pathogen interactions at the University of Massachusetts in 2003. He is currently a tenuredAssociate Professor of microbiology at the University of Massachusetts Amherst. His research has focused on Chlamydia vaccine development and the role of pathogenic microbes in asthma initiation and exacerbation. The Webley Lab is using immunoinformatics and the gas vesicle nanoparticles of Halobacteria as a platform for multi-subunit antigen display and have confirmed that this system is a potentially effective display and delivery platform for antigens of chlamydial vaccine interest.His laboratory was the first to culture Chlamydia from bronchoalveolar lavage samples taken from pediatric patients with chronic, severe asthma and has since shown that early life chlamydial infection increases the risk for asthma onset. His recent work has demonstrated the efficacy of antibiotics in treating a subset of severe asthmatics. His work has been published in reputable international journals and has made significant contributions to the field of microbiology, vaccinology, allergy and immunology. He is a member of the International Society for Vaccines, American Society for Microbiology, the Chlamydia Basic Research Society and Sigma XI - The Scientific Research Society.


Wilmore C. Webley

Associate Professor


  • : (413) 577- 3139
    Fax: (413) 545-1578

  • DEPARTMENTDepartment of Microbiology
    University of Massachusetts Amherst